E-Mail
IMAGE: Dr. Malanga (right) and Dr. Tyson-Hudson (center) conduct a follow-up examination on a wheelchair user with spinal cord injury. view more
Credit: Kessler Foundation/Jody Banks
East Hanover, NJ. May 12, 2021. A team of specialists in regenerative rehabilitation conducted a successful pilot study investigating micro-fragmented adipose tissue (MFAT) injection for rotator cuff disease in wheelchair users with spinal cord injury. They demonstrated that MFAT injection has lasting pain-relief effects. The article, A pilot study to evaluate micro-fragmented adipose tissue injection under ultrasound guidance for the treatment of refractory rotator cuff disease in wheelchair users with spinal cord injury, (doi: 10.1080/10790268.2021.1903140) was published ahead of print on April 8, 2021, by the
Credit: Specna Arms
East Hanover, NJ. May 5, 2021. Kessler Foundation received a $219,941 award from The Geneva Foundation for a two-year study: MIRROR Collaboration: A novel treatment for neck pain in active-duty military personnel: The Cervigard Neck Collar. This funding builds upon the Foundation s participation as one of the civilian sites participating in the Musculoskeletal Injury Rehabilitation Research for Operational Readiness (MIRROR) program, headquartered at the Uniformed Services University (USU) in Bethesda, Maryland.
Lead investigators are Nathan Hogaboom, PhD, co-director of the Derfner-Lieberman Laboratory for Regenerative Rehabilitation Research at Kessler Foundation, and Gerard Malanga, MD, director of New Jersey Regenerative Institute and a visiting scientist at Kessler Foundation. Cervigard is a product of Cervigard Spinal Bracing Corporation in Bloomfield, New Jersey.
Kessler team receives funding to study factors leading to osteoarthritis after knee injury
Gerard Malanga, MD, and Nathan Hogaboom, PhD, of Kessler Foundation received a $185,707 award from The Geneva Foundation (Geneva) to study factors contributing to the development of osteoarthritis following acute knee injuries, a common disabling condition among active-duty military personnel.
The funding supports Kessler Foundation s participation as a collaborative partner in Musculoskeletal Injury and Rehabilitation Research for Operational Readiness (MIRROR) headquartered at the Uniformed Services University (USU).
The MIRROR program is managed by Geneva on behalf of USU. MIRROR supports a broad scope of musculoskeletal projects, including this two-year study entitled, MIRROR Collaboration: Chemical and cellular characterization of hemarthroses after traumatic knee injuries in active-duty military personnel.